Tag: Verzenio

In the monarchE clinical trial for high-risk early breast cancer, adding Verzenio to hormone therapy for two years reduced the risk of cancer recurrence by 35% compared to hormone therapy alone [1.3.3]. This article explains how many years you can take Verzenio for based on your diagnosis.

The monthly retail cost of Verzenio without insurance can exceed $8,000, placing a significant financial burden on patients. This makes understanding how to get Verzenio cheaper a crucial part of a comprehensive treatment plan for many patients managing their breast cancer expenses.

Clinical trial data show that infections, including urinary tract infections (UTIs), are a common side effect for patients taking Verzenio (abemaciclib). The medication can lead to a reduced white blood cell count, a condition known as neutropenia, which compromises the immune system and increases the overall risk of developing infections.

Verzenio, with the active ingredient abemaciclib, was first approved by the FDA in September 2017 to treat certain types of breast cancer. This groundbreaking medication is currently only available as a brand-name drug, which prompts many patients to ask: **Is there a generic drug for Verzenio?**.

According to the monarchE trial, adding abemaciclib to standard hormone therapy significantly reduced the risk of invasive disease recurrence by over 25% for patients with high-risk, HR+, HER2- early breast cancer. Abemaciclib (brand name Verzenio) is a targeted cancer therapy that has revolutionized treatment for this specific patient population.